Gut microbiota versus mental health: discoveries that could impact psychiatric treatment protocols
DOI:
https://doi.org/10.25118/2763-9037.2024.v14.1074Keywords:
intestinal microbiota, Mental Health, intestine, brain, psychobiotics, gastrointestinal microbiome, brain gut microbiome axisAbstract
Introduction: The discovery of bidirectional communication between the intestine and brain has sparked interest in understanding the role of the intestinal microbiota in regulating emotional processes. Objective: To analyze the mechanism of direct influence of the intestinal microbiota on the nervous system and point out possible challenges faced in the treatment strategy, addressing possible impacts on treatment protocols. Method: This is an integrative literature review research whose purpose was to gather and summarize the studies already published between the period 2013 and 2023 on the topic investigated in order to meet the proposed objectives. Results: Around 1,400 published articles were found, with a noticeable increase in the number of publications from 2012 onwards. After applying the inclusion criteria and discussing the articles found among the authors, 07 articles were selected that included at least one of the proposed objectives for the investigation of the proposed topic. Discussion: Based on the knowledge of the mechanisms of disruption of the intestinal microbiota, combined with the neurobiology of mental disorders, it is possible to associate psychobiotic medications as treatment enhancers in the approach to mental health. Since, the state of eubiosis can directly contribute to the success of pharmacological treatment. Conclusion: It is necessary to develop a healthy intestinal microbiota to achieve homeostasis, ensuring protection, maintenance of the immune function of the intestinal mucosa, absorption of nutrients and regulation of neurotransmitters important in mental health.
Downloads
Metrics
References
.1. Cryan JF, O'Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, Codagnone MG, Cussotto S, Fulling C, Golubeva AV, Guzzetta KE, Jaggar M, Long-Smith CM, Lyte JM, Martin JA, Molinero-Perez A, Moloney G, Morelli E, Morillas E, O'Connor R, Cruz-Pereira JS, Peterson VL, Rea K, Ritz NL, Sherwin E, Spichak S, Teichman EM, van de Wouw M, Ventura-Silva AP, Wallace-Fitzsimons SE, Hyland N, Clarke G, Dinan TG. The microbiota-gut-brain axis. Physiol Rev. 2019;99(4):1877-2013. https://doi.org/10.1152/physrev.00018.2018 - PMID:31460832 DOI: https://doi.org/10.1152/physrev.00018.2018
.2. Berding K, Vlckova K, Marx W, Schellekens H, Stanton C, Clarke G, Jacka F, Dinan TG, Cryan JF. ,Diet and the microbiota-gut-brain axis: sowing the seeds of good mental health. Adv Nutr. 2021;12(4):1239-85. https://doi.org/10.1093/advances/nmaa181 PMID:33693453 PMCID:PMC8321864 DOI: https://doi.org/10.1093/advances/nmaa181
.3. Bektas A, Erdal H, Ulusoy M, Uzbay IT. Does seratonin in the intestines make you happy? Turk J Gastroenterol. 2020;31(10):721-3. https://doi.org/10.5152/tjg.2020.19554 - PMID:33169710 PMCID:PMC7659911 DOI: https://doi.org/10.5152/tjg.2020.19554
.4. Butler MI, Morkl S, Sandhu KV, Cryan JF, Dinan TG. The gut microbiome and mental health: what should we tell our patients?: Le microbiote intestinal et la santé mentale: que devrions-nous dire à nos patients? Can J Psychiatry. 2019;64(11):747-60. https://doi.org/10.1177/0706743719874168 - PMID:31530002 - PMCID:PMC6882070 DOI: https://doi.org/10.1177/0706743719874168
.5. Marese ACM, Ficagna EJ, Parizotto RA, Linartevichi VF. Principais mecanismos que correlacionam a microbiota intestinal com a patogênese da depressão. FAG J Health. 2019;1(3):232-9. https://doi.org/10.35984/fjh.v1i2.40 DOI: https://doi.org/10.35984/fjh.v1i2.40
.6. Castro ML, Ratto RS, Coelho KV, Bampi SR, Raphaelli CO, Peter NB. A influência da alimentação na microbiota e a relação com distúrbios como ansiedade e depressão. Braz J Dev. 2021;7(7):74087-111. https://doi.org/10.34117/bjdv7n7-542 DOI: https://doi.org/10.34117/bjdv7n7-542
.7. Santos LC, Welter A. Modulação da microbiota intestinal por probióticos como alternativa para o tratamento da depressão: uma revisão bibliográfica. Singular. 2020;1(1):41-8. https://doi.org/10.33911/singularsb.v1i1.83 DOI: https://doi.org/10.33911/singularsb.v1i1.83
.8. Christofolett GSF, Paiva NLC, Pinheiro GJ, Ferreira TC. O microbioma intestinal e a interconexão com os neurotransmissores associados a ansiedade e depressão. Braz J Health Rev. 2022;5(1):3385-408. https://doi.org/10.34119/bjhrv5n1-298 DOI: https://doi.org/10.34119/bjhrv5n1-298
.9. Jian C, Carpén N, Helve O, de Vos WM, Korpela K, Salonen A. Early-life gut microbiota and its connection to metabolic health in children: perspective on ecological drivers and need for quantitative approach. EBioMedicine. 2021;69:103475. https://doi.org/10.1016/j.ebiom.2021.103475 - PMID:34256346 - PMCID:PMC8324810 DOI: https://doi.org/10.1016/j.ebiom.2021.103475
.10. Tonini IGO, Vaz DSS, Mazur CE. Eixo intestino-cérebro: relação entre a microbiota intestinal e desordens mentais. Res Soc Dev. 2020;9(7):e499974303. https://doi.org/10.33448/rsd-v9i7.4303 DOI: https://doi.org/10.33448/rsd-v9i7.4303
.11. Lassmann L, Pollis M, Zóltowska A, Manfredini D. Gut bless your pain-roles of the gut microbiota, sleep, and melatonin in chronic orofacial pain and depression. Biomedicines. 2022;10(7):1528. https://doi.org/10.3390/biomedicines10071528 PMID:35884835 PMCID:PMC9313154 DOI: https://doi.org/10.3390/biomedicines10071528
.12. Silva KCJ, Brito MGJP, Lima AA, Viana MDM. Psicobióticos: alternativas potenciais aos ansiolíticos convencionais? Res Soc Dev. 2021;10(4):e40810414102. https://doi.org/10.33448/rsd-v10i4.14102 DOI: https://doi.org/10.33448/rsd-v10i4.14102
.13. Lach G, Morais LH, Costa APR, Hoeller AA. Envolvimento da flora intestinal na modulação de doenças psiquiátricas. Vittalle. 2017;29(1):64-82. https://doi.org/10.14295/vittalle.v29i1.6413 DOI: https://doi.org/10.14295/vittalle.v29i1.6413
.14. Morkl S, Butler MI, Holl A, Cryan JF, Dinan TG. Probiotics and the microbiota-gut-brain axis: focus on psychiatry. Curr Nutr Rep. 2020;9(3):171-82. https://doi.org/10.1007/s13668-020-00313-5 PMID:32406013 - PMCID:PMC7398953 DOI: https://doi.org/10.1007/s13668-020-00313-5
Del Toro-Barbosa M, Hurtado-Romero A, Garcia-Amezquita LE, García-Cayuela T. Psychobiotics: mechanisms of action, evaluation methods and effectiveness in applications with food products. Nutrients. 2020;12(12):3896. https://doi.org/10.3390/nu12123896 - PMID:33352789 PMCID:PMC7767237 DOI: https://doi.org/10.3390/nu12123896
.16. Barbosa GA, Duarte Neto JMW. Psicobióticos e suas influências nos tratamentos de depressão e ansiedade. Nutrivisa. 2021;8(1):E9633. https://doi.org/10.59171/nutrivisa-2021v8e9633 DOI: https://doi.org/10.59171/nutrivisa-2021v8e9633
.17. Medeiros CIS, Costa TP. Repercussão da microbiota intestinal na modulação do sistema nervoso central e sua relação com doenças neurológicas. Rev Cienc Med Biol. 2020;19(2):342-6. https://doi.org/10.9771/cmbio.v19i2.29390 DOI: https://doi.org/10.9771/cmbio.v19i2.29390
.18. Bastiaanssen TFS, Cussotto S, Claesson MJ, Clarke G, Dinan TG, Cryan JF. Gutted! Unraveling the role of the microbiome in major depressive disorder. Harv Rev Psychiatry. 2020;28(1):26-39. https://doi.org/10.1097/hrp.0000000000000243 PMID:31913980 - PMCID:PMC7012351 DOI: https://doi.org/10.1097/HRP.0000000000000243
.19. Sharma R, Gupta D, Mehrotra R, Mago P. Psychobiotics: the next-generation probiotics for the brain. Curr Microbiol. 2021;78(2):449-63. https://doi.org/10.1007/s00284-020-02289-5 PMID:33394083 DOI: https://doi.org/10.1007/s00284-020-02289-5
.20. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13(10):701-12. https://doi.org/10.1038/nrn3346 PMID:22968153 DOI: https://doi.org/10.1038/nrn3346
.21. Twardowska A, Makaro A, Binienda A, Fichna J, Salaga M. Preventing bacterial translocation in patients with leaky gut syndrome: nutrition and pharmacological treatment options. Int J Mol Sci. 2022;23(6):3204. https://doi.org/10.3390/ijms23063204 - PMID:35328624 - PMCID:PMC8949204 DOI: https://doi.org/10.3390/ijms23063204
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Audrey Ribeiro Fischer, Hayslla Mikaella do Couto Araújo
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Debates em Psiquiatria allows the author (s) to keep their copyrights unrestricted. Allows the author (s) to retain their publication rights without restriction. Authors should ensure that the article is an original work without fabrication, fraud or plagiarism; does not infringe any copyright or right of ownership of any third party. Authors should also ensure that each one complies with the authorship requirements as recommended by the ICMJE and understand that if the article or part of it is flawed or fraudulent, each author shares responsibility.
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) - Debates em Psiquiatria is governed by the licencse CC-By-NC
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
